Carregant...

Targeting Functional Biomarkers in Schizophrenia with Neuroimaging

Many of the most debilitating symptoms for psychiatric disorders such as schizophrenia remain poorly treated. As such, the development of novel treatments is urgently needed. Unfortunately, the costs associated with high failure rates for investigational compounds as they enter clinical trials has l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Pharm Des
Autors principals: Wylie, Korey P., Smucny, Jason, Legget, Kristina T., Tregellas, Jason R.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854787/
https://ncbi.nlm.nih.gov/pubmed/26818860
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!